Bin Li
Director of Computational Biology, Takeda Data Science Institute @ Takeda
Boston, United States
Bin Li is a director of computational biology at Takeda Data Science Institute. His team provides computational supports on translational and biomarker research for various Takeda compounds. They develop computational methods for exploratory data analysis, build translational predictive models and data repositories for patient stratification anddisease indication selection efforts. His team is also responsible for method evaluation and pipeline building for various NGS platforms, including WES, RNA-seq, and targeted NGS panels.
Last updated:
For AI agents: llms.txt
About Takeda
Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.
Takeda Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Plump
President, Research & Development
|
|||
|
Bin Li
Director of Computational Biology, Takeda Data Science Institute
|
|||
|
Ceri Davies
Head of CNS Drug Discovery Unit
|
|||
Christopher Barr
Takeda Community Engagement
|
|||
Masaru Otsuka
Head of Digital Acceleration
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
